What is claimed is a compound represented by the following structural formula: 1 or a pharmaceutically acceptable salt, solvate or clathrate thereof. The variables for Structural Formula (I) are as described herein.
Web www.patentalert.com
< Methods of using IL-1 antagonists to treat autoinflammatory disease
< Polypeptide derivatives of parathyroid hormone (PTH)
> Pharmaceutical composition
> Methods for the treatment of synucleinopathies
HOME | NEW USER | LOGIN | SUBSCRIPTIONS | SEARCH | GUESTBOOK | CONTACT